Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Pavlidis

Showing results (41-50 of 191) with videos related to

Pageof 20
Sort By:
International Journal of Cancer|May 31, 2019
Cancer of unknown primary: Incidence rates, risk factors and survival among adolescents and young adultsNicholas Pavlidis, Elie Rassy, Julie Smith-Gagen
European Journal of Cancer (Oxford, England : 1990)|November 3, 2018
Liquid biopsy: a new diagnostic, predictive and prognostic window in cancers of unknown primaryElie El Rassy, Hussein Khaled, Nicholas Pavlidis
European Journal of Clinical Investigation|March 26, 2019
A new entity of abdominal squamous cell carcinoma of unknown primaryElie El Rassy, Joseph Kattan, Nicholas Pavlidis
Cancer Treatment Reviews|May 26, 2005
Brain metastasis of unknown primary: a diagnostic and therapeutic dilemmaKonstantinos S Polyzoidis, George Miliaras, Nicholas Pavlidis
Critical Reviews in Oncology/Hematology|October 21, 2015
Cancer specific risk in multiple sclerosis patientsAthanasios P Kyritsis, Stergios Boussios, Nicholas Pavlidis
Cancer Treatment Reviews|December 3, 2008
Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature reviewGeorge Pentheroudakis, F A Greco, Nicholas Pavlidis
Clinical Prostate Cancer|March 30, 2004
Biweekly administration of low-dose docetaxel in hormone-resistant prostate cancer: pilot study of an effective subtoxic therapyVasilis Karavasilis, Evangelos Briasoulis, Olga Siarabi, et al.
Journal of the National Cancer Institute|February 3, 2005
Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysisDavide Mauri, Nicholas Pavlidis, John P A Ioannidis
Thyroid : Official Journal of the American Thyroid Association|July 21, 2005
Oxaliplatin (Eloxatin) plus irinotecan combination chemotherapy found effective in refractory metastatic insular thyroid carcinomaEvangelos Briasoulis, Demetra Rontogianni, Vasilis Karavasilis, et al.
Cancer Treatment Reviews|May 23, 2006
Cancer treatment reviews welcomes submission of the Cochrane ReviewsNicholas Pavlidis, Rolf Stahel, Mike Clarke, et al.
Pageof 20

Showing results (41-50 of 191) with videos related to

Sort By:
Pageof 20
International Journal of Cancer|May 31, 2019
Cancer of unknown primary: Incidence rates, risk factors and survival among adolescents and young adultsNicholas Pavlidis, Elie Rassy, Julie Smith-Gagen
European Journal of Cancer (Oxford, England : 1990)|November 3, 2018
Liquid biopsy: a new diagnostic, predictive and prognostic window in cancers of unknown primaryElie El Rassy, Hussein Khaled, Nicholas Pavlidis
European Journal of Clinical Investigation|March 26, 2019
A new entity of abdominal squamous cell carcinoma of unknown primaryElie El Rassy, Joseph Kattan, Nicholas Pavlidis
Cancer Treatment Reviews|May 26, 2005
Brain metastasis of unknown primary: a diagnostic and therapeutic dilemmaKonstantinos S Polyzoidis, George Miliaras, Nicholas Pavlidis
Critical Reviews in Oncology/Hematology|October 21, 2015
Cancer specific risk in multiple sclerosis patientsAthanasios P Kyritsis, Stergios Boussios, Nicholas Pavlidis
Cancer Treatment Reviews|December 3, 2008
Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature reviewGeorge Pentheroudakis, F A Greco, Nicholas Pavlidis
Clinical Prostate Cancer|March 30, 2004
Biweekly administration of low-dose docetaxel in hormone-resistant prostate cancer: pilot study of an effective subtoxic therapyVasilis Karavasilis, Evangelos Briasoulis, Olga Siarabi, et al.
Journal of the National Cancer Institute|February 3, 2005
Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysisDavide Mauri, Nicholas Pavlidis, John P A Ioannidis
Thyroid : Official Journal of the American Thyroid Association|July 21, 2005
Oxaliplatin (Eloxatin) plus irinotecan combination chemotherapy found effective in refractory metastatic insular thyroid carcinomaEvangelos Briasoulis, Demetra Rontogianni, Vasilis Karavasilis, et al.
Cancer Treatment Reviews|May 23, 2006
Cancer treatment reviews welcomes submission of the Cochrane ReviewsNicholas Pavlidis, Rolf Stahel, Mike Clarke, et al.
Pageof 20